Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.17 (
CaMKII
)
4,029
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Calcium/calmodulin (Ca2+/CaM)-dependent protein kinase II (
CaMKII
) couples increases in cellular Ca2+ to fundamental responses in excitable cells.
CaMKII
was identified over 20 years ago by activation dependence on Ca2+/CaM, but recent evidence shows that
CaMKII
activity is also enhanced by pro-oxidant conditions. Here we show that oxidation of paired regulatory domain methionine residues sustains
CaMKII
activity in the absence of Ca2+/CaM.
CaMKII
is activated by angiotensin II (AngII)-induced oxidation, leading to apoptosis in cardiomyocytes both in vitro and in vivo.
CaMKII
oxidation is reversed by
methionine sulfoxide reductase A
(
MsrA
), and
MsrA
-/- mice show exaggerated
CaMKII
oxidation and myocardial apoptosis, impaired cardiac function, and increased mortality after myocardial infarction. Our data demonstrate a dynamic mechanism for
CaMKII
activation by oxidation and highlight the critical importance of oxidation-dependent
CaMKII
activation to AngII and ischemic myocardial apoptosis.
...
PMID:A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. 1845 79